A carregar...

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

INTRODUCTION: The efficacy of a cholinesterase inhibitor, donepezil, in patients with dementia with Lewy bodies (DLB) was investigated to confirm the superiority over placebo in the 12-week, double-blind phase of this phase III study. METHODS: Patients with probable DLB (n = 142) were randomly assig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Ikeda, Manabu, Mori, Etsuro, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338565/
https://ncbi.nlm.nih.gov/pubmed/25713599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0083-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!